AIRWAY REMODELLING, ASTHMATIC

Clinical trials for AIRWAY REMODELLING, ASTHMATIC explained in plain language.

Never miss a new study

Get alerted when new AIRWAY REMODELLING, ASTHMATIC trials appear

Sign up with your email to follow new studies for AIRWAY REMODELLING, ASTHMATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Can a drug reverse Asthma's hidden airway damage?

Disease control Completed

This phase 3 trial tests whether tezepelumab, an injectable drug, can reverse airway wall thickening (remodeling) in adults with asthma. Participants, aged 18 to 85 with moderate-to-severe asthma, will receive either tezepelumab or a placebo for about a year. Researchers will use…

Matched conditions: AIRWAY REMODELLING, ASTHMATIC

Phase: PHASE3 • Sponsor: University Hospital, Montpellier • Aim: Disease control

Last updated Jul 11, 2026 00:00 UTC

AIRWAY REMODELLING, ASTHMATIC

Get alerted when new AIRWAY REMODELLING, ASTHMATIC trials appear

Can a drug reverse Asthma's hidden airway damage?